Optimizing NK Cell-Based Immunotherapy in Myeloid Leukemia: Abrogating an Immunosuppressive Microenvironment

Area of Science:

• Immunology
• Cancer Immunotherapy
• Innate Immune System

Background:

• Natural killer (NK) cells are key cytotoxic and cytokine-producing innate immune cells.
• NK cell-based immunotherapies show promise for advanced-stage and high-risk acute myeloid leukemia (AML).
• Challenges include tumor microenvironment immunosuppression and NK cell metabolic dysfunction.

Purpose of the Study:

• To review current NK cell sources for immunotherapy.
• To highlight interventions for enhancing NK cell function.
• To outline strategies for overcoming tumor microenvironment barriers.

Main Methods:

• Review of existing literature on NK cell sources and therapies.
• Analysis of methods to improve NK cell expansion, activation, and persistence.
• Discussion of strategies to counteract tumor-induced immunosuppression.

Main Results:

• Multiple NK cell sources are identified (e.g., haploidentical, CAR-NK, iNKT).
• Approaches to enhance NK cell generation and function are being developed.
• Circumventing tumor microenvironment immunosuppression is critical for efficacy.

Conclusions:

• Optimizing NK cell generation and function is crucial for effective myeloid leukemia treatment.
• Overcoming the immunosuppressive tumor microenvironment is essential for successful NK cell immunotherapy.
• Further research into novel strategies will expand the future success of NK cell therapies in leukemia.